Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

LUCD

+ Watchlist+ Portfolio

Lucid Diagnostics Inc.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.40
52-Week Range
$0.30 – $1.63
Market Cap
$79.38M
P/E (TTM)
—
EPS (TTM)
-0.36
Dividend Yield
0.00%
Advanced Metrics
Price/Book
13.15
PEG Ratio
—
Return on Equity
-305.59%
Return on Assets
-78.96%
Gross Margin
-16.52%
Operating Margin
-941.89%
Profit Margin
0.00%
Current Ratio
1.20
Debt/Equity
3.12
Total Debt
$18.49M
Free Cash Flow
$-30.78M
Revenue Growth
-0.70%
Earnings Growth
—
Enterprise Value
$78.84M

Market Snapshot

About

Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company focused on esophageal cancer detection. The company develops non-invasive tests for early detection of esophageal precancer and cancer, including the EsoGuard test. Their technology aims to improve patient outcomes through earlier diagnosis of esophageal adenocarcinoma and its precursor condition, Barrett's esophagus.